Skip to main content
High RiskFDAfda-F-1321-2013UNDECLARED ALLERGEN

Bakehouse Granola, 12 oz, 340 g Scholar's Inn Bakehouse Granola 16 oz, 454 g All Natural, Baked locally

Units Affected
0
Recall Date
March 25, 2013
Issuing Agency
Hazard
Undeclared Allergen

FDA Recall Notice

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1321-2013.

Bake House Granola, does not list the source of the unsalted butter ingredient as milk, an allergen. People who have an allergy or severe sensitivity to milk, run the risk of serious or life-threatening allergic reaction if they consume these products.

Corrective Action (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1321-2013.

Recall terminated by FDA.

✅ What you should do

  1. Stop using the product if you own it.
  2. Check the model number, lot code, or sell-by date against the recall notice above.
  3. Contact Sib, Inc. or the retailer where you bought it for a refund, replacement, or repair.
  4. For the most current official instructions, visit the FDA recall page.
  5. If you've been hurt by this product, report the incident to FDA.

Consumer Contact (per FDA)

Source: U.S. Food and Drug Administration (FDA) — official FDA notice for recall FDA-F-1321-2013.

SIB, Inc.

FDA

About the U.S. Food and Drug Administration

The FDA regulates drugs, medical devices, food, cosmetics, and tobacco. Adverse event reports and recall notices are the main public safety signal.

Visit FDA.gov →

📣 Report a food, supplement, or cosmetic problem to the FDA

If you had a reaction, found contamination, or experienced a labeling problem with this product, report it to the FDA. The agency uses consumer reports to track emerging safety signals and trigger recalls.

How to report to FDAFile a report at FDA

Sib, Inc. Recall FAQ

Sib, Inc. is the subject of a bakery & grains safety report: Bakehouse Granola, 12 oz, 340 g Scholar's Inn Bakehouse Granola 16 oz, 454 g All Natural, Baked locally. The notice was published on March 25, 2013 by the U.S. Food and Drug Administration (FDA). Approximately 0 units are potentially affected.